VFA
FLXN

Valeo Financial Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Valeo Financial Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-392
Closed -$3K – 2241
2020
Q1 		$3K Hold
392
– – ﹤0.01% 1466
2019
Q4 		$8K Hold
392
– – ﹤0.01% 1179
2019
Q3 		$5K Buy
392
+23
+6% +$273 ﹤0.01% 1219
2019
Q2 		$5K Hold
369
– – ﹤0.01% 1234
2019
Q1 		$5K Buy
369
+171
+86% +$2.29K ﹤0.01% 1209
2018
Q4 		$2K Sell
198
-115
-37% -$1.8K ﹤0.01% 1342
2018
Q3 		$4K Buy
313
+101
+48% +$2.32K ﹤0.01% 1308
2018
Q2 		$5K Sell
212
-64
-23% -$1.66K ﹤0.01% 1166
2018
Q1 		$6K Hold
276
– – ﹤0.01% 1105
2017
Q4 		$7K Buy
276
+179
+185% +$4.38K ﹤0.01% 939
2017
Q3 		$2K Buy
+97
New +$2.28K ﹤0.01% 1056

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return